XML 65 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue - Gilead Sciences Inc (Details) - USD ($)
$ in Thousands
 7 Months Ended 12 Months Ended
Oct. 14, 2022
Jul. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Collaboration and Other Agreements [Line Items]          
Revenues     $ 58,749 $ 151,941 $ 77,447
Gilead | 2022 Gilead Collaboration And License Agreement          
Collaboration and Other Agreements [Line Items]          
Non-refundable upfront payment   $ 60,000      
Target nomination, option fees and milestone $ 1,700,000        
Revenues     1,500 200  
Deferred revenue     58,300 59,800  
Deferred revenue, current     2,200 1,800  
Deferred revenue, noncurrent     56,100 $ 58,000  
Gilead | Gilead First Research Program          
Collaboration and Other Agreements [Line Items]          
Revenues     800    
Deferred revenue     14,900    
Deferred revenue, current     11,800    
Deferred revenue, noncurrent     3,100    
Revenue, remaining performance obligation, amount     15,700    
Opt-in fee     $ 10,000